UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Treatment of relapsed or refractory mantle cell lymphoma

Authors

Arnold S Freedman, MD

Section Editor — Lymphoproliferative Disorders

Professor of Medicine

Harvard Medical School

Jonathan W Friedberg, MD

Professor of Medicine

James P Wilmot Cancer Center, University of Rochester

Section Editor

Andrew Lister, MD, FRCP, FRCPath, FRCR

Section Editor — Lymphoproliferative Disorders

Professor of Medical Oncology

St. Bartholomew's Hospital, London

Deputy Editor

Alan G Rosmarin, MD

Deputy Editor — Hematology

Professor of Medicine

University of Massachusetts Medical School

Peer Reviewer

Reviewers are not identified on topic reviews to preserve anonymity